Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical Carcinoma

Hockel, 1996, Hypoxia and radiation response in human tumors, Semin Radiat Oncol, 6, 3, 10.1016/S1053-4296(96)80031-2

Sutherland, 1996, Tumor hypoxia and heterogeneity: Challenges and opportunities for the future, Semin Radiat Oncol, 6, 59, 10.1016/S1053-4296(96)80036-1

Hockel, 1996, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res, 56, 4509

Tannock, 1982, Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interactions of the drugs with radiation, Cancer Res, 42, 4921

Graeber, 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours, Nature, 379, 88, 10.1038/379088a0

Young, 1988, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells, Proc Natl Acad Sci USA, 85, 9533, 10.1073/pnas.85.24.9533

Brizel, 1997, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck, Int J Radiat Oncol Biol Phys, 38, 285, 10.1016/S0360-3016(97)00101-6

Hall, 1994

Raleigh, 1996, Measuring tumor hypoxia, Semin Radiat Oncol, 6, 37, 10.1016/S1053-4296(96)80034-8

Raleigh, 1987, Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours, Br J Cancer, 56, 395, 10.1038/bjc.1987.213

Arteel, 1995, Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver, Br J Cancer, 72, 889, 10.1038/bjc.1995.429

Azuma, 1996, Lifetime of hypoxic cells in spontaneous canine tumors, Radiat Res, 148, 35, 10.2307/3579536

Kennedy, 1997, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays, Int J Radiat Oncol Biol Phys, 37, 897, 10.1016/S0360-3016(96)00539-1

Raleigh, 1990, Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules, Biochem Pharmacol, 40, 2457, 10.1016/0006-2952(90)90086-Z

Cline, 1994, Distribution of the hypoxia marker CC1-103F in canine tumors, Int J Radiat Oncol Biol Phys, 28, 921, 10.1016/0360-3016(94)90113-9

Raleigh, 1994, An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours, Br J Cancer, 69, 66, 10.1038/bjc.1994.10

Thrall, 1994, ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation, Int J Radiat Oncol Biol Phys, 28, 649, 10.1016/0360-3016(94)90190-2

Garcia, 1987, Quantitation and estimation of lymphocyte subsets in tissue sections: Comparison with flow cytometry, Am J Clin Pathol, 87, 470, 10.1093/ajcp/87.4.470

Saunders, 1984, The clinical testing of Ro 03-8799: pharmacokinetics, toxicology, tissue and tumor concentrations, Int J Radiat Oncol Biol Phys, 10, 1759, 10.1016/0360-3016(84)90544-3

Roberts, 1984, A phase I study of the hypoxic cell radiosensitizer Ro-03-8799, J Radiat Oncol Biol Phys, 10, 1755, 10.1016/0360-3016(84)90543-1

Foley, 1993, Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats, Environ Health Perspect, 101, 199, 10.1289/ehp.93101s5199

Chou, S-C, Yates, J, Raleigh, J, Development of hypoxia markers for clinical use: Pimonidazole. 1996

Raleigh, 1995, Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors, Acta Oncol, 34, 345, 10.3109/02841869509093987

Secomb, 1995, Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors, Acta Oncol, 34, 313, 10.3109/02841869509093981

Vaupel, 1987, Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats, Cancer Res, 47, 3496

Hansgen, 1997, Intratumor pO2, Strahlenther Onkol, 173, 385

Gross, 1995, Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids, Int J Cancer, 61, 567, 10.1002/ijc.2910610422

Cline, 1997, Quantification of CCI-103F labeling heterogeneity in canine solid tumors, Int J Radiat Oncol Biol Phys, 37, 655, 10.1016/S0360-3016(96)00559-7

Brown, 1996, Hypoxia-specific cytotoxins in cancer therapy, Semin Radiat Oncol, 6, 22, 10.1016/S1053-4296(96)80033-6

Shweiki, 1995, Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis, Proc Natl Acad Sci USA, 92, 768, 10.1073/pnas.92.3.768